GlassScriptPhysician profile
Daniel L Crocker
NPI 1700886272
$1,587.30
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $183 · 2022: $14.76.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $389.97 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $248.57 | 2019-2020 | |
| Glaxosmithkline, LLC. | $181.63 | 2019 | |
| Amgen INC. | $158.45 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $118.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.68 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $78.62 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.17 | 2019 | |
| Pfizer INC. | $49.68 | 2019 | |
| Amarin Pharma, INC. | $26.69 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $17.83 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.31 | 2019 | |
| Grifols USA, LLC | $16.53 | 2019 | |
| Avanir Pharmaceuticals, INC. | $15.46 | 2019 | |
| Abbvie INC. | $14.76 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $13.33 | 2019 | |
| Shionogi INC | $13.33 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.26 | 2019 | |
| Hikma Pharmaceuticals USA | $12.10 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.74 | 2019 | |
| Merck Sharp & Dohme LLC | $10.83 | 2019 | |
| Astellas Pharma US INC | $10.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Crocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.